These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30551735)

  • 1. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; Jansma IP; De Vet HCW; Coupé VMH
    Clin Colorectal Cancer; 2018 Mar; 17(1):e1-e12. PubMed ID: 28734786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; de Vet HCW; Coupé VMH
    J Cancer Educ; 2020 Apr; 35(2):345-351. PubMed ID: 30685832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of palliative care for patients with unresectable metastatic colorectal cancer in China: a questionnaire-based survey].
    Wang F; Chen DL; Wang ZX; He Y; Li J; Zhang SZ; Chen G; Xu JM; Yuan XL; Zhang YQ; Xu RH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jul; 27(7):718-725. PubMed ID: 39004987
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
    Oostendorp LJ; Ottevanger PB; van de Wouw AJ; Honkoop AH; Los M; van der Graaf WT; Stalmeier PF
    J Cancer Educ; 2016 Sep; 31(3):443-8. PubMed ID: 25985960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?
    Au L; Turner N; Wong HL; Field K; Lee B; Boadle D; Cooray P; Karikios D; Kosmider S; Lipton L; Nott L; Parente P; Tie J; Tran B; Wong R; Yip D; Shapiro J; Gibbs P
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e167-e174. PubMed ID: 28299879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
    Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
    Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision support systems for incurable non-small cell lung cancer: a systematic review.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; Jansma EP; De Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):144. PubMed ID: 28969629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06).
    Strasser F; Blum D; von Moos R; Cathomas R; Ribi K; Aebi S; Betticher D; Hayoz S; Klingbiel D; Brauchli P; Haefner M; Mauri S; Kaasa S; Koeberle D;
    Ann Oncol; 2016 Feb; 27(2):324-32. PubMed ID: 26646758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
    Mohile SG; Magnuson A; Pandya C; Velarde C; Duberstein P; Hurria A; Loh KP; Wells M; Plumb S; Gilmore N; Flannery M; Wittink M; Epstein R; Heckler CE; Janelsins M; Mustian K; Hopkins JO; Liu J; Peri S; Dale W
    J Natl Compr Canc Netw; 2018 Mar; 16(3):301-309. PubMed ID: 29523669
    [No Abstract]   [Full Text] [Related]  

  • 11. Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review.
    Miller ED; Klamer BG; Cloyd JM; Pawlik TM; Williams TM; Hitchcock KE; Romesser PB; Mamon HJ; Ng K; Gholami S; Chang GJ; Anker CJ
    Clin Colorectal Cancer; 2024 Jun; 23(2):160-173. PubMed ID: 38365567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists' clinical deliberation.
    Otte I; Salloch S; Reinacher-Schick A; Vollmann J
    BMC Cancer; 2017 Nov; 17(1):780. PubMed ID: 29162047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
    Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
    Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologists' Views on Using Value to Guide Cancer Treatment Decisions.
    Gidwani-Marszowski R; Nevedal AL; Blayney DW; Patel M; Kelly PA; Timko C; Ramchandran K; Murrell SS; Asch SM
    Value Health; 2018 Aug; 21(8):931-937. PubMed ID: 30098670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line treatment choices of Turkish medical oncologists in metastatic colorectal cancer: A survey study.
    Beypinar I; Araz M; Uysal M; Yalcin S
    J BUON; 2019; 24(1):68-76. PubMed ID: 30941953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.
    Puts MT; Sattar S; McWatters K; Lee K; Kulik M; MacDonald ME; Jang R; Amir E; Krzyzanowska MK; Leighl N; Fitch M; Joshua AM; Warde P; Tourangeau AE; Alibhai SM
    Support Care Cancer; 2017 Mar; 25(3):879-886. PubMed ID: 27830393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
    Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
    Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC.
    Cramer-van der Welle CM; Kastelijn EA; Plouvier BC; van Uden-Kraan CF; Schramel FMNH; Groen HJM; van de Garde EMW
    JCO Clin Cancer Inform; 2021 May; 5():570-578. PubMed ID: 34010031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologists' End of Life Treatment Decisions.
    Bluhm M; Connell CM; Janz N; Bickel K; DeVries R; Silveira M
    J Appl Gerontol; 2017 Apr; 36(4):416-440. PubMed ID: 26198272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.